|
Volumn 50, Issue 3, 1996, Pages 143-147
|
The bone marrow peptide (myelopeptide-2) abolishes induced by human leukemia HL-60 cell suppression of T lymphocytes
|
Author keywords
CD3, CD4 and CD8 antigens; Leukemic HL 60 cells; Myelopeptides (MPs); Proliferative response; T lymphocytes
|
Indexed keywords
CD3 ANTIGEN;
CD4 ANTIGEN;
CD8 ANTIGEN;
MYELOPEPTIDE;
SYNTHETIC PEPTIDE;
ADULT;
ARTICLE;
CANCER IMMUNOTHERAPY;
CELL LINE;
FLOW CYTOMETRY;
HUMAN;
HUMAN CELL;
LEUKEMIA CELL;
NORMAL HUMAN;
PHENOTYPE;
PRIORITY JOURNAL;
T LYMPHOCYTE;
|
EID: 0029891478
PISSN: 01652478
EISSN: None
Source Type: Journal
DOI: 10.1016/0165-2478(96)02527-8 Document Type: Article |
Times cited : (13)
|
References (8)
|